Outcomes when congenital heart disease is diagnosed antenatally versus postnatally in the UK: a retrospective population-based study by unknown
RESEARCH ARTICLE Open Access
Outcomes when congenital heart disease is
diagnosed antenatally versus postnatally in the
UK: a retrospective population-based study
Lewis K Peake*, Elizabeth S Draper, Judith LS Budd and David Field
Abstract
Background: For major congenital heart disease, the benefits of antenatal diagnosis on some post-natal measures
have been suggested. However, findings have been inconclusive and focus on short term outcome measures alone
with little data from a UK population. Our aim is to describe differences in reported outcomes for patients born with
isolated Hypoplastic Left Heart Syndrome or Transposition of the Great Arteries in a UK population, following either
antenatal or postnatal diagnosis.
Methods: Retrospective population-based study with case note review covering a 15 year period (1st January 1998
to 31st December 2012) in the British county of Leicestershire. Cases were identified from two local registers: the
East Midlands and South Yorkshire Congenital Anomaly Register and a list of surgical patient held by the East
Midlands Congenital Heart Centre.
Results: In total 52 cases of Hypoplastic Left Heart Syndrome or Transposition of the Great Arteries were identified
with 24 (46.2%) diagnosed antenatally. Maximum and minimum follow up was 181 and 16 months respectively.
Median follow up was 83 months (IQR: 44–111).
The risk of intubation in the postnatal period (OR: 4.64, 95% CI: 1.40 - 15.32) was greater in cases of Hypoplastic Left
Heart Syndrome or Transposition of the Great Arteries diagnosed after birth when compared to those diagnosed
antenatally. There was a non-significant increase in the risk of metabolic acidosis in the postnatal period (OR: 12.5,
95% CI: 0.64 - 245.46). No differences in mortality or long-term outcomes were demonstrated between antenatally
and postnatally diagnosed cohorts.
Conclusions: These results confirm data from American and European populations that, for a British population, an
antenatal diagnosis of a major congenital heart disease can have a favourable impact on some postnatal outcome
measures. There appears to be no evidence that time of diagnosis impacts on long-term outcome measures.
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Background
In the UK, one in 180 children is born with Congenital
Heart Disease (CHD) [1]. Diagnosis can be made ante-
natally - something which has become increasingly com-
mon since the routine implementation of 20-week fetal
anomaly scanning and the development of modern ultra-
sonography [2] - or following symptom presentation in
the post natal period.
It has been suggested that short term outcomes in
congenital heart disease would improve with antenatal
diagnosis because birth in an appropriate setting can be
planned in terms of the timing of delivery and immedi-
ate access to specialist staff and facilities [3]. In addition,
those neonates without an antenatal diagnosis are at risk
of discharge without their condition being identified,
despite routine baby checks. Where the child is affected
by major congenital heart disease that is essentially un-
stable, this can lead to haemodynamic compromise and
result in emergency admission. Similarly, access to surgi-
cal intervention may be delayed, or else undertaken with
the patient in a sub-optimal condition [4].
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Despite this sound reasoning, and whilst improve-
ments in some postnatal measures with an antenatal
diagnosis have been demonstrated [5-8], such benefits
have not been identified consistently. Much of the exist-
ing literature focuses on reviews that are based within
tertiary care centres, thus limiting cases to a highly se-
lective group with the greatest potential to survive.
There is little reporting of longer term outcomes and
sparse data concerning a relevant British population.
Objectives
The aim of the study was to explore the effect of ante-
natal diagnosis on congenital heart disease mortality and
long term morbidity within a British population.
The specific objectives where to:
 Investigate if an antenatal diagnosis of transposition
of the great arteries (TGA) or Hypoplastic left heart
syndrome (HLHS) results in improved short term
outcomes, i.e. neonatal mortality, risk of metabolic
acidosis, Apgar score and need for intubation in the
perinatal period.
 Investigate if an antenatal diagnosis of TGA or
HLHS correlated with an improvement in long term
outcomes, i.e. late mortality, neurodevelopmental




This study comprised a retrospective analysis of out-
come data in patients diagnosed with Hypoplastic Left
Heart Syndrome or Transposition of the Great Arteries
whose mothers lived within the British county of
Leicestershire, which has an annual birth rate of ap-
proximately 11,000 per year. From 2010 all pregnant
women were offered fetal anomaly scanning at around
20 weeks of gestation. From 1998 to 2010 such scan-
ning was offered to a significant proportion of women
but was not universal.
Cases were identified from two separate sources: the
East Midlands and South Yorkshire congenital anomalies
register (EMSYCAR) and the cardiac surgical database
held by the East Midlands Congenital Heart Centre
(EMCHC). This cross validation of cases was used to
ensure complete ascertainment and facilitate accuracy
regarding the epidemiology of major congenital heart
disease in Leicestershire. A standardised data collec-
tion proforma was used to gather information from the
medical records.
Isolated Hypoplastic Left Heart Syndrome (HLHS) and
Transposition of the Great Arteries (TGA) were chosen
for investigation based on their relatively high case num-
bers locally, case homogeneity and existing literature
suggesting a significant proportion of cases were diag-
nosed antenatally in pregnancies subject to fetal anomaly
scanning.
Setting
All cases of Hypoplastic Left Heart Syndrome and
Transposition of the Great Arteries born within the
county of Leicestershire between 1st January 1998 and
31st December 2012 were identified. A case note review
was then attempted. Identification was primarily through
the East Midlands and South Yorkshire Congenital
Anomalies Register [9]. This database collects data on
all congenital anomalies diagnosed across its constituent
counties and is one of a network of 12 regional/disease
specific registers that make up the British Isles Network
of Congenital Anomaly Registers (BINOCAR) [10]. A
database of surgical patients held by the local tertiary
care centre (East Midlands Congenital Heart Centre,
EMCHC) was used for validation and identification of
additional cases.
Participants
A search of the EMSYCAR database was undertaken for
diagnoses of ICD-10 Q234 (HLHS) and Q203 (TGA)
born in the study period. Cases were limited to those
with a Leicestershire postcode at birth.
A separate list of cases was created from the database
of surgical patients held by the EMCHC (Glenfield
Hospital, Leicester) for the same period. Clinical notes
were then reviewed and relevant data extracted. This
comprised clinical information only to ensure anonymity
and to comply with information governance; no patient
identifiers were recorded.
Within the existing literature there is inconsistency in
the approach to cases with a chromosomal diagnosis in
terms of inclusion/exclusion [11-13]. Ultimately it was
decided to exclude all cases with a confirmed chromo-
somal defect in order to provide a clearer picture of the
implications of antenatal diagnosis for isolated defects.
Cases were also excluded if found to have additional car-
diac defects outside those typically seen with diagnoses of
HLHS or TGA. A ventricular septal defect in a case of
TGA (a common association) was not an exclusion criter-
ion. Cases with major extra-cardiac malformations likely
to impact on morbidity or mortality were also excluded.
Variables
Data points collected were grouped into three life stages:
the birth and postnatal period, the surgical period and
the post-surgical period (see Table 1). Items within the
surgical period group were incomplete for some cases
due to intervention in hospitals outside of the East
Midlands Congenital Heart Centre. All data were as doc-
umented in the clinical case notes.
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Study size
As a local population-based study, it was limited by the
number of cases of HLHS and TGA born within the
available time-frame of 15 years, the period of data col-
lection for the EMSYCAR database.
Statistical methods
Data were collated and analysed with IBM SPSS Statistics
20. Antenatal detection rates for each condition were
compared to the 50% target set by the Fetal Anomaly
Screening Programme (FASP) [14]. Comparisons between
the outcomes detected in the antenatal and postnatal co-
horts were made, with odds ratios and 95% confidence in-
tervals calculated. Where data items were missing from
the notes, cases were excluded from the specific outcome
analysis between cohorts.
Ethics
Ethics permission was provided by the Trent research
ethics committee in relation to the East Midlands and
South Yorkshire Congenital Anomalies Register.
Results
Participants
Search of both databases identified 32 HLHS and 52
TGA cases. Two of the HLHS cases identified from
EMSYCAR were later downgraded to milder cardiac de-
fects (Shone’s Complex and Patent Foramen Ovale with
Ventricular Septal Defect) and were excluded from ana-
lysis. Four HLHS and 11 TGA cases were excluded due
to an association with a chromosomal diagnosis or for
concurrent cardiac defects (see Figure 1).
At case note review, a further 15 cases (Four HLHS
and 11 TGA) had to be excluded as insufficient clinical
data could be accessed. Total cases used in the final ana-
lysis numbered 22 for HLHS and 30 for TGA. Perinatal
outcome analysis was also carried out for both condi-
tions combined. This was based on all 52 cases; 24 in
the antenatally detected cohort and 28 in the postnatally
detected cohort (see Figure 1).
Descriptive data
Case characteristics are outlined in Table 2. The max-
imum and minimum follow up periods were 181 and
16 months respectively. Median follow up was 83 months
(IQR: 44–111).
In the HLHS group nearly three quarters were ante-
natally diagnosed. There were no significant differences
between the birth weight or gestational age in the ante-
natally and postnatally detected cohorts and all but one
case for each cohort had surgery. For the TGA group,
two thirds were postnatally diagnosed and there were no
Table 1 Collected data items
Birth/Postnatal period
Birth status Stillborn, Liveborn, Liveborn later died
Gestational age Rounded to the nearest week
Delivery method Vaginal, Assisted Vaginal, Elective C-S, Emergency C-S
Apgar @ 5 mins
Acidosis in postnatal period pH < 7.35 on any Arterial Blood Gas within postnatal period
Intubation Needed mechanical ventilation prior to surgery
Surgical period
Listed Yes or No. If no, reason: i.e. Parental or MDT choice
Weight at time of surgery Grammes
Age at time of surgery Days
Cardiopulmonary bypass time Minutes
Cross-clamp time Minutes
Length of post-op ICU stay Hours if <4 days; days if >4 days
Surgical mortality Mortality between induction and post-op ICU discharge.
Post-surgical period
Ongoing cardiac symptoms Adjudged at max follow-up. E.g. SOB, decreased exercise tolerance
Ongoing cardiac medications Adjudged at max follow-up. E.g. β-blockers, Diuretics
Need for re-intervention
Neurodevelopmental impairment Referral to specialist service (e.g. SALT) or specific diagnosis (e.g. Cerebral Palsy of Developmental delay)
Mortality
Summary of the data items collected for each case, split into the postnatal period, surgical period and the post-surgical/long-term period.
SOB: Shortness of Breath. SALT: Speech and Language Therapist.
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significant differences in birth weight or gestational age be-
tween the antenatally and postnatally diagnosed cohorts.
Outcome data
Outcome measures for the antenatal and postnatal co-
horts of HLHS and TGA are presented in Table 3 and
Table 4.
For HLHS, the major differences between the two co-
horts were in the postnatal measures. Of the antenatal co-
hort, 75% had a recorded metabolic acidosis compared to
100% in the postnatal cohort - OR: 4.68 (95% CI: 0.21 -
100.99). The antenatal cohort was less likely to require in-
tubation and mechanical ventilation in the postnatal
period but due to the small numbers the odds ratio did
not quite reach significance: 31.3% vs. 83.3% - OR: 11
(95% CI: 1.00 - 120.44). Assessment of the surgical
measures was difficult for the HLHS group as many pa-
tients received surgery outside of the local tertiary paediat-
ric cardiac care centre. Neither cohort experienced
significantly better long-term outcome measures such as
ongoing symptoms (Antenatal: 80%, Postnatal: 25% - OR:
0.08 (95% CI: 0.01 - 1.29)), neurodevelopmental issues
(Antenatal: 20%, Postnatal: 20%) or long-term mortality
(see Table 3).
For the TGA group, there was also a difference in the
numbers requiring intubation in the postnatal period.
Intubation was documented in just one case (12.5%) of
antenatally diagnosed neonates with TGA, compared to
12 (54.5%) of those diagnosed postnatally - OR: 8.40 (95%
CI: 0.88 - 80.27). Surgical measures could be assessed for
this group, but no difference in age at surgery (p = 0.39),
weight at surgery (p = 0.40) or length of post-op ICU stay
Figure 1 Summary of case inclusion/exclusion. Summary of case numbers of TGA and HLHS and those lost due to exclusion. Antenatal and
postnatal cohorts were compared for each diagnosis, then collectively. A: Number of cases identified from EMSYCAR and EMCHC database
searches. B: All cases minus those excluded due to change of diagnosis at birth. C: Minus those excluded due to chromosomal diagnosis.
D: Minus those excluded due to extra-cardiac manifestations or cardiac complexity.
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(p = 0.89) was found. Similarly there were no differences
in long-term outcome measures between the two cohorts.
When the two diagnoses were combined (see Table 5),
there was a significant difference in the risk of requiring
intubation for those diagnosed postnatally - OR: 4.64
(95% CI: 1.40 - 15.32). There was also an increased risk
of metabolic acidosis - OR: 12.5 (95% CI: 0.64 - 245.46)
but this was not significant. The only patients to die




This study has highlighted two specific outcomes where
an antenatal diagnosis is favourable - risk of metabolic
acidosis and need for postnatal intubation. The finding
is seen most clearly in the combined cohorts and this ap-
proach of combining the effect on differing anomalies has
been reported previously in the American and European
literature for both outcomes [7,8]. Our findings suggest
that antenatal diagnosis of HLHS and TGA in the UK re-
sults in improved perinatal outcomes. However in relation
to the increased risk of intubation in the postnatally diag-
nosed cohort this could reflect a more cautious approach
to treatment in this patient group where, at presentation,
there is often a range of diagnostic possibilities.
Conversely, where a provisional diagnosis already exists
treating clinicians may be prepared to adopt a more con-
servative approach to management. We noted no differ-
ence in later outcomes or in terms of overall survival
when comparing antenatally and postnatally diagnosed
cases.
Interpretation
The impact of antenatal diagnosis on some perinatal
outcomes has been reported previously. Fuchs et al. [5]
investigated >250 patients over a 10 year period across
four different diagnoses (including TGA), with an 83%
antenatal detection rate. The maximum follow up period
was 130 months, with a median of 37.8 months. In the
prenatally diagnosed cohort, evidence of pre-operative
cardiac failure, need for re-surgery and duration of post-
operative ICU stay were all found to be significantly
favourable (p-value ≤ 0.05) compared to those diagnosed
postnatally. Long-term, they found no difference in de-
pendency on cardiac medication or long term survival
between the two groups. However, being based in a ter-
tiary care centre, they were unable to include patients
without a prenatal diagnosis who died before they were
transferred to their unit.
Calderon et al. [6] also explored some longer term
outcomes, specifically the effect of prenatal detection of
Table 2 Patient characteristics by diagnosis
HLHS (Ant) HLHS (Post) OR (95% CI) or p-value
Number of cases 16 6
Antenatally diagnosed, % 72.7
Gender:
Female, n(%) 11 (68.8) 2 (33.3)
Male, n(%) 5 (31.2) 4 (66.7)
Median birth weight, g(IQR) 3042 (2720–3392) 3780 (3490–4100) p = 0.08
Median gestational age, weeks(IQR) 39 (38–39) 40.5 (38–42) p = 0.17
C-Section, n(%) 4 (25.0) 2 (33.3) 1.50 (0.20 - 11.54)
Received surgical intervention, n(%) 15 (93.8) 5 (83.3) 3.00 (0.16 - 57.37)
TGA (Ant) TGA (Post) OR (95% CI) or p-value
Number of cases 8 22
Antenatally diagnosed, % 36.4
Gender:
Female, n(%) 1(12.5) 2 (9.1)
Male, n(%) 7 (87.5) 20 (90.9)
Median birth weight, g(IQR) 3525 (3415–3870) 3400 (3200–3600) p = 0.49
Median gestational age, weeks(IQR) 39 (38–41) 40 (38.5 - 41) p = 0.37
C-section, n(%) 1 (12.5) 3 (13.6) 1.10 (0.10 - 12.47)
Received surgical intervention, n(%) 8 (100) 21 (95.5) 1.19 (0.04 - 32.08)
This table summarises the case characteristics for HLHS and TGA patients by diagnostic stage. There were no significant differences in birth parameters between
the antenatal and postnatal cohort. The strong predominance for Male Transposition of the Great Arteries cases is unexpected and unexplained.
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TGA on neurocognitive development. This prospective
study showed a correlation between postnatal diagnosis
and a less favourable score in “cognitive flexibility” and
“social cognition”. Both results were statistically signifi-
cant and highlighted the need for further investigation
in terms of how congenital heart disease can impact on
neurodevelopment.
Levey et al. [15] looked at a wider range of congenital
heart diseases. Their four year retrospective review in-
cluded 439 cases of varying diagnoses, creating a large
heterogeneous group with widely disparate outcomes.
They highlighted a reduced risk of preoperative intub-
ation (OR 0.62, p = 0.033) and emergency surgery (OR
0.18, p < 0.001) in the prenatally diagnosed cohort. No
differences were demonstrated in mortality or neonatal
measures such as Apgar score or time to surgery.
Limitations
This study aimed to overcome the potential bias of simi-
lar papers, identifying cases from a geographically de-
fined population rather than just those referred to a
single tertiary centre. In this way, postnatally diagnosed
cases that did not undergo surgery were included. Des-
pite this, surgical data could not be gathered for those
operated on outside the East Midlands Congenital Heart
Centre, which could limit the interpretation of some of
the long term outcomes gathered.
The EMSYCAR database relies on case notification
from medical professions. Multiple notifications per case
are encouraged to ensure high levels of ascertainment,
but some degree of incomplete referral is likely. As fetal
detection is one key point for referral, the postnatally
diagnosed cohorts are the most likely groups to have
been subject to such an affect.
External validity
All cases were Leicestershire born. The county has a
strong reputation for the treatment of congenital heart
disease which may or may not be comparable to other
areas of the UK. The impact of this local specialist ser-
vice on parental decision making regarding maintenance
of an antenatally diagnosed CHD pregnancy is unknown.
The balance of antenatal and postnatal cohorts may have
been affected by this.
Table 3 Outcome measures for antenatally, postnatally diagnosed HLHS
Hypoplastic left heart syndrome Antenatal diagnosis Postnatal diagnosis OR (95% CI) or p-value
Liveborn cases 16 6
Case status
Liveborn - alive: 10 5
Liveborn - later died: 6 1
Postnatal Median Apgar Score 9 9 n/a
Pre-operative Acidosis, n(%) 12 (75.0) 6 (100.0) 4.68 (0.21 - 100.99)
Intubation, n(%) 5 (31.3) 5 (83.3) 11 (1.00 - 120.44)
Mortality within first week, n(%) 0 (−) 1 (16.7) n/a
Surgical Attempted Surgery, n 15 5 n/a
Median Age at Surgery (IQR), days 3.5 (3–7.5) 7 (5–21.5) p = 0.16
Median Weight at Surgery (IQR), gram 3060 (2900–3510) 3900 (2360–4200) n/a
Median Bypass Time (IQR), mins 153 (123.5 - 192.5) 134 (117–151) n/a
Length of ICU Stay Post Surgery, days 16.5 (7–27.5) 11 (8–14.5) n/a
Long-term outcome 30 day survival (all Liveborn) 75.0% (12/16) 83.3% (5/6) 0.60 (0.05 - 6.80)
1 Year survival (all Liveborn) 62.5% (10/16) 83.3% (5/6) 0.33 (0.31 - 3.58)
3 Year survival (all Liveborn <2010) 76.9% (10/13) 80.0% (4/5) 0.83 (0.66 - 10.60)
5 Year survival (all Liveborn <2008) 75.0% (6/8) 75.0% (3/4) n/a
10 Year Survival (all Liveborn <2003) - (0/0) 50.0% (1/2) n/a
Documented neurodevelopment issues, n 4/10 2/5 p = 1.00
Cases requiring on-going cardiac medication, n 9/9 4/4 n/a
Cases with ongoing cardiac symptoms (All), n 8/10 1/4 0.08 (0.01 - 1.29)
Cases with ongoing cardiac symp. (Fontan), n 3/4 1/3 n/a
Comparison between outcomes seen in patients with antenatally and postnatally detected Hypoplastic Left Heart Syndrome over three life periods: postnatal
period, surgical period and long-term.
Denominators for long-term outcomes decreased as cases were lost from analysis due to absence of clinical information.
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Bias
With respect to the neuro-developmental outcomes, a
potential source of bias is the increased follow-up
afforded to some cases. It is possible that the cases
which are more medically unstable (and therefore have
more frequent reviews) will be more likely to have a
negative outcome diagnosed and recorded if present,
than those cases that are reviewed less frequently.
The study utilised two separate patient registers to
overcome the potential selection bias of other papers
Table 4 Outcome measures for antenatally, postnatally diagnosed TGA
Transposition of the great arteries Antenatal diagnosis Postnatal diagnosis OR (95% CI) or p-value
Liveborn cases 8 22
Case status
Liveborn - alive: 8 19
Liveborn - later died: 0 3
Postnatal Median Apgar Score (IQR) 9 (8–9) 9 (9–9) n/a
Pre-operative Acidosis, n(%) 8 (100.0) 22 (100.0) n/a
Intubation, n(%) 1 (12.5) 12 (54.5) 8.40 (0.88 - 80.27)
Mortality within first week, n(%) 0 (0.0) 1(4.5) 1.19 (0.04 - 32.08)
Surgical Attempted Surgery 8 21 n/a
Median Age at Surgery (IQR), days 12.5 (6–26) 29.5 (10–29) p = 0.39
Median Weight at Surgery (IQR), gram 3900 (3400–3920) 3450 (3200–4205) p = 0.40
Median Bypass Time (IQR), mins 170 (144–227) 189 (177–269) p = 0.50
Length of ICU Stay Post Surgery, days 5 (3.5 - 19) 8 (5–8) p = 0.89
Post-Op Complication, n(%) 2 / 8 (25.0) 2 / 21 (9.5) 0.32 (0.32 - 2.75)
Long-term outcome 30 day survival (all Liveborn) 100% (8/8) 90.9% (20/22) 2.07 (0.09 - 47.90)
1 Year survival (all Liveborn) 100% (8/8) 86.3% (19/22) 3.05 (0.14 - 65.78)
3 Year survival (all Liveborn <2010) 100% (6/6) 83.3% (15/18) 2.94 (0.13 - 65.26)
5 Year survival (all Liveborn <2008) 100% (5/5) 85.7% (12/14) 2.20 (0.09 - 53.85)
10 Year Survival (all Liveborn <2003) 100% (2/2) 83.3% (5/6) n/a
Documented neurodevelopment issues 1/8 3/19 1.31 (0.12 - 14.93)
Cases with post-surgical cardiac symptoms 1/8 3/15 1.75 (0.15 - 20.23)
Cases requiring cardiac medication 2/8 3/15 0.75 (0.10 - 5.77)
Comparison between outcomes seen in patients with antenatally and postnatally detected Transposition of the Great Arteries over three life periods: postnatal
period, surgical period and long-term.
Denominators for long-term outcomes decreased as cases were lost from analysis due to absence of clinical information.
Table 5 Outcome measures for anteatally, postnatally diagnosed isolated HLHS or TGA
Antenatal diagnosis Postnatal diagnosis OR (95% CI) or p-value
Liveborn cases 24 28
Case status
Liveborn - alive: 18 24
Liveborn - later died: 6 4
Short term Median Apgar Score 9 9 *
Pre-operative Acidosis, n(%) 20/24 (83.3) 28/28 (100.0) 12.5 (0.64 - 245.46)
Intubation, n(%) 6/24 (25.0) 17/28 (60.7) 4.64 (1.40 - 15.32)
Mortality within first week, n(%) 0/24 (−) 2/28 (7.1) 4.62 (0.21 - 101.16)
30 day survival 83.3% (20/24) 89.3% (25/28) 0.60 (0.12 - 3.00)
1 Year survival 75.0% (18/24) 85.7% (24/28) 0.50 (0.12 0 2.04)
Comparison between cases antenatally and postnatally diagnosed with isolated HLHS or TGA. Short term outcomes only were included due to the
appropriateness of analysing long-term outcomes for a disparate group.
Peake et al. BMC Pediatrics  (2015) 15:58 Page 7 of 8
with a similar focus, i.e. those based in a specialist centre
which focused only on cases which underwent surgery.
The majority of cases were already present on both data-
bases, suggesting high levels of reporting.
Conclusion
This small study, based on a geographically defined
population, has been able to confirm the findings of pre-
vious case series of apparent short term benefits of ante-
natal over post natal diagnosis. No differences in longer
term outcomes were identified and this too is in keeping
with previous case series. However both the nature of
previous studies and the relatively small number of pa-
tients reviewed here means that any effect on long term
outcome is uncertain. Rates of adverse neurodevelop-
mental outcome in babies with major congenital heart
disease remain relatively high and merit further investi-
gation to understand fully whether antenatal diagnosis
has the potential to improve longer term outcome.
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